查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
智能吸入器市場規模,份額和趨勢分析報告：按類型（乾粉/定量吸入器）,適應症（哮喘,慢性阻塞性肺病）,分銷渠道,最終用途,地區,細分市場預測2022-2030
市場調查報告書
商品編碼
1170894

智能吸入器市場規模,份額和趨勢分析報告：按類型（乾粉/定量吸入器）,適應症（哮喘,慢性阻塞性肺病）,分銷渠道,最終用途,地區,細分市場預測2022-2030

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

智能吸入器市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告，到 2030 年，全球智能吸入器市場規模預計將達到 533 億美元，2022 年至 2030 年的複合年增長率為 19.3%。哮喘、慢性阻塞性肺病 (COPD)、囊性纖維化和肺部疾病等慢性呼吸系統疾病 (CRD) 患病率上升有助於市場增長。據歐洲呼吸學會大會稱，COPD 預計到 2022 年將影響全球超過 4.8 億人。

由於用於呼吸和肺部護理的尖端數字設備和解決方案日益普及，COVID-19 增加了對智能吸入器的需求。此外，在大流行後時代，智能吸入器的採用率正在上升，因為醫療保健提供者希望連接的醫療設備能夠幫助患者在任何情況下都獲得更好、更好的護理。

此外，越來越多的企業將數字技術融入到他們的產品中，以提高用藥效率和管理哮喘和慢性阻塞性肺病。同樣在 2022 年 4 月，市場領導者 Aptar Pharma 宣布推出 HeroTracker Sense，這是一種新型數字慢性呼吸電子健康解決方案，可將傳統計量吸入器轉變為智能吸入器。此外，對 Aderium 智能吸入器的研究還表明，智能吸入器用戶獲得了多項有益的醫療成果，包括住院時間減少、服藥依從性提高以及就診需求減少。

智能吸入器市場報告要點

按類型劃分，計量吸入器 (MDI) 部分將在 2021 年佔據最大份額，超過 60.0%。MDI 是用於治療 CRD 的最優選吸入器。乾粉吸入器 (DPI) 部分預計在預測期內以 18.6% 的最快速度增長，這是由於易於使用的給藥機制帶來的便利。

據指徵，慢阻肺的患病率很高，全球有2億人受到影響，到2021年，慢阻肺細分市場將佔據最大份額，超過50.0%。由於哮喘住院人數增加，尤其是幼兒，預計在預測期內，哮喘部分將以 18.3% 的最快速度增長。

從分銷渠道來看，2021年醫院藥房板塊佔比最大，超過40.0%。老年人經常因 CRD 住院治療，我們正在考慮到醫院藥房購買藥物。由於現有藥店的快速擴張和現代化以提高市場滲透率，預計零售藥店部門在預測期內將以 19.2% 的速度增長

按最終用戶劃分，醫院部分將在 2021 年佔據最大份額，超過 50.0%，因為醫院是製藥公司與患者之間的重要分銷渠道。家庭醫療環境領域預計在預測期內將以最快的速度增長 20.2%，這是受老年患者偏好上升、醫療成本上升以及家庭護理提供的便利性推動。

2021 年，由於 CRD 在該地區的流行率上升，北美以超過 45.0% 的份額主導了市場。美國有超過 2500 萬人患有哮喘病。由於中國和印度等發展中國家慢性阻塞性肺病和哮喘發病率上升，預計亞太地區在預測期內將以最快的速度增長 21.2%

目錄

第一章研究範圍與目的

  • 市場細分和範圍
  • 區域範圍
  • 目的

第二章研究方法論

  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析（模型一）
    • 量價分析（模型二）
  • 二級信息列表

第三章執行摘要

  • 市場展望
  • 分部展望
    • 類型
    • 展示
    • 分銷渠道
    • 最終用途
    • 地區
  • 競爭考慮
  • 2021 年智能吸入器市場展望

第 4 章市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 智能吸入器市場動態
    • 市場驅動力分析
    • 市場約束因素分析
  • 智能吸入器市場：商業環境分析工具
    • 波特五力分析
      • 新進入者的威脅
      • 供應商的議價能力
      • 買方議價能力
      • 競爭對手之間的競爭
      • 替代品的威脅
    • PESTEL 分析
      • 政治與法律
      • 經濟與社會
      • 技術的
      • 環境
  • 繪製滲透率和增長前景
  • 技術趨勢分析
  • 監管框架
  • COVID-19 對智能吸入器市場的影響

第五章智能吸入器市場：類型分析

  • 2021 年和 2030 年智能吸入器類型市場份額分析
  • 智能吸入器類型市場：細分儀表板
  • 類型細分市場規模和預測，趨勢分析，2017-2030
    • 乾粉吸入器
    • 定量吸入器

6. 智能吸入器市場：適應症分析

  • 2021 年和 2030 年智能吸入器適應症市場份額分析
  • 智能吸入器適應市場：細分儀表板
  • 2017-2030年適應症細分市場規模及預測、趨勢分析
    • 哮喘
    • Copd
    • 其他

第七章智能吸入器市場：分銷渠道分析

  • 2021 年和 2030 年智能吸入器分銷渠道市場份額分析
  • 智能吸入器分銷渠道市場：細分儀表板
  • 分銷渠道市場規模和預測，趨勢分析，2017-2030
    • 醫院藥房
    • 零售藥店
    • 網上藥店

8. 智能吸入器市場：最終用途分析

  • 智能吸入器最終用途市場份額分析，2021 年和 2030 年
  • 智能吸入器最終用途市場：細分儀表板
  • 2017-2030 年最終用途細分市場規模及預測及趨勢分析
    • 醫院
    • 家庭護理設置
    • 其他

第 9 章智能吸入器市場：區域分析

  • 智能吸入器區域市場份額分析，2021 年和 2030 年
  • 區域市場快照
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 10 章 競爭分析

  • 主要市場進入者的最新發展和影響分析
  • 公司簡介
    • H&T PRESSPART MANUFACTURING LTD.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • PERSONAL AIR QUALITY SYSTEMS PRIVATE LIMITED
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • COHERO HEALTH INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • COGNITA LABS
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • ADHERIUM LIMITED
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AMIKO DIGITAL HEALTH LIMITED
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • TEVA PHARMACEUTICALS INDUSTRIES LTD.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • PROPELLER HEALTH
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • NOVARTIS AG
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • PNEUMA RESPIRATORY, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • 3M HEALTH CARE LIMITED
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • FINDAIR SP Z O O
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AIREHEALTH, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-993-1

Smart Inhalers Market Growth & Trends:

The global smart inhalers market size is expected to reach USD 53.3 billion by 2030, based on a new report by Grand View Research, Inc., expanding at a CAGR of 19.3% from 2022 to 2030. The rising prevalence of chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and lung disorders is contributing to the growth of the market. According to the European Respiratory Society Congress, COPD is expected to affect over 480 million people in 2022 across the globe.

COVID-19 has increased the demand for smart inhalers due to the rising penetration of cutting-edge digital devices and solutions for respiratory and pulmonary care. Furthermore, in the post-pandemic era, it is expected that the adoption of smart inhalers will increase as healthcare providers are focusing on connected medical devices to ensure that patients receive better and more enhanced care, regardless of the circumstance.

Furthermore, a growing number of businesses are incorporating digital technologies into their products to improve the efficiency of medication and the management of asthma and COPD. In addition, in April 2022, Aptar Pharma, a key market player, introduced HeroTracker Sense, a novel digital chronic respiratory e-health solution that converts a traditional metered dose inhaler into a smart inhaler. Furthermore, a study of the Adherium Smart inhaler also revealed that smart inhaler users experienced several beneficial medical outcomes, including fewer hospitalizations, improved medication adherence, and a decreased need for doctor visits.

Smart Inhalers Market Report Highlights:

  • Based on type, the metered dose inhalers (MDIs) segment held the largest share of over 60.0% in 2021. MDIs are the most preferred inhalers used to treat CRDs. The dry powdered inhalers (DPIs) segment is expected to register the fastest growth rate of 18.6% over the forecast period owing to the convenience of its mechanism, which makes it easier to use for medicine delivery
  • Based on indication, the COPD segment held the largest share of over 50.0% in 2021 due to the high prevalence of COPD as it affects 200 million people globally. The asthma segment is anticipated to grow at the fastest rate of 18.3% over the forecast period owing to the rising number of hospitalizations for asthma, particularly in young children
  • Based on distribution channel, the hospital pharmacies segment held the largest share of over 40.0% in 2021. The elderly population frequently receives hospital care for CRDs, and they consider purchasing medication from hospital pharmacies. The retail pharmacies segment is anticipated to grow at a rate of 19.2% over the forecast period due to the quick expansion and modernization of the existing pharmacies to increase market penetration
  • Based on end-use, the hospitals segment accounted for the largest share of over 50.0% in 2021 as hospitals are a crucial distribution channel between pharmaceutical companies and patients. The home care settings segment is anticipated to grow at the fastest rate of 20.2% over the forecast period due to the growing preference among older patients, rising costs of healthcare, and the convenience offered by the treatments at home
  • In 2021, North America dominated the market with a share of over 45.0% owing to the rising prevalence of CRDs in the region. In the U.S., more than 25 million people suffer from asthma. Asia Pacific is expected to expand at the fastest rate of 21.2% during the forecast period owing to rising incidence rates of COPD and asthma in developing nations such as China and India

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation & Scope
  • 1.2 Regional Scope
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Objectives
    • 1.3.1 Objective - 1
    • 1.3.2 Objective - 2
    • 1.3.3 Objective - 3

Chapter 2 Methodology

  • 2.1 Research Methodology
  • 2.2 Information Procurement
    • 2.2.1 Purchased Database
    • 2.2.2 Gvr's Internal Database
    • 2.2.3 Secondary Sources
    • 2.2.4 Primary Research
  • 2.3 Information or Data Analysis
    • 2.3.1 Data Analysis Models
  • 2.4 Market Formulation & Validation
  • 2.5 Model Details
    • 2.5.1 Commodity Flow Analysis (Model 1)
    • 2.5.2 Volume Price Analysis (Model 2)
  • 2.6 List of Secondary Sources

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 type
    • 3.2.2 Indication
    • 3.2.3 distribution Channel
    • 3.2.4 end-Use
    • 3.2.5 Region
  • 3.3 Competitive Insights
  • 3.4 Smart Inhalers Market Outlook, 2021

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Ancillary Market Outlook
  • 4.2 Smart Inhalers Market Dynamics
    • 4.2.1 Market Driver Analysis
    • 4.2.2 Market Restraint Analysis
  • 4.3 Smart Inhalers Market: Business Environment Analysis Tools
    • 4.3.1 Porter's Five Forces Analysis
      • 4.3.1.1 Threat Of New Entrants
      • 4.3.1.2 Bargaining Power Of Suppliers
      • 4.3.1.3 Bargaining Power Of Buyers
      • 4.3.1.4 Competitive Rivalry
      • 4.3.1.5 Threat Of Substitutes
    • 4.3.2 Pestel Analysis
      • 4.3.2.1 Political & Legal
      • 4.3.2.2 Economic & social
      • 4.3.2.3 Technological
      • 4.3.2.4 Environmental
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Technology Trend Analysis
  • 4.6 Regulatory Framework
  • 4.7 Impact of COVID-19 on Smart Inhalers Market

Chapter 5 Smart Inhalers Market: Type Analysis

  • 5.1 Smart Inhalers Type Market Share Analysis, 2021 & 2030
  • 5.2 Smart Inhalers Type Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment
    • 5.3.1 Dry Powdered Inhalers
      • 5.3.1.1 Dry Powdered Inhalers (Dpis) Market, 2017 - 2030 (USD Million)
    • 5.3.2 Metered Dose Inhalers
      • 5.3.2.1 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)

Chapter 6 Smart Inhalers Market: Indication Analysis

  • 6.1 Smart Inhalers Indication Market Share Analysis, 2021 & 2030
  • 6.2 Smart Inhalers Indication Market: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Indication Segment
    • 6.3.1 Asthma3
      • 6.3.1.1 Asthma Market, 2017 - 20302017 - 20302017 - 2030 (USD Million)
    • 6.3.2 Copd
      • 6.3.2.1 Copd Market, 2017 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Others market, 2017 - 2030 (USD Million)

Chapter 7 Smart Inhalers Market: Distribution Channel Analysis

  • 7.1 Smart Inhalers Distribution Channel Market Share Analysis, 2021 & 2030
  • 7.2 Smart Inhalers Distribution Channel Market: Segment Dashboard
  • 7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Distribution Channel
    • 7.3.1 Hospitals Pharmacies
      • 7.3.1.1 Hospitals Pharmacies Market, 2017 - 2030 (USD Million)
    • 7.3.2 Retail Pharmacies
      • 7.3.2.1 Retail Pharmacies Market, 2017 - 2030 (USD Million)
    • 7.3.3 Online Pharmacies
      • 7.3.3.1 Online pharmacies market, 2017 - 2030 (USD Million)

Chapter 8 Smart Inhalers Market: End-Use Analysis

  • 8.1 Smart Inhalers end-use Market Share Analysis, 2021 & 2030
  • 8.2 Smart Inhalers End-Use Market: Segment Dashboard
  • 8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment
    • 8.3.1 Hospitals
      • 8.3.1.1 Hospitals Market, 2017 - 2030 (USD Million)
    • 8.3.2 Homcare Settings
      • 8.3.2.1 Homecare Settings Market, 2017 - 2030 (USD Million)
    • 8.3.3 Others
      • 8.3.3.1 Others market, 2017 - 2030 (USD Million)

Chapter 9 Smart Inhalers Market: Regional Analysis

  • 9.1 Smart Inhalers Regional Market Share Analysis, 2021 & 2030
  • 9.2 Regional Market Snapshot
  • 9.3 North America
    • 9.3.1 North America Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.3.2 U.S.
      • 9.3.2.1 U.S. Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.3.3 Canada
      • 9.3.3.1 Canada Smart Inhalers Market, 2017 - 2030 (USD Million)
  • 9.4 Europe
    • 9.4.1 Europe Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.2 U.K.
      • 9.4.2.1 U.K. Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.3 Germany
      • 9.4.3.1 Germany Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.4 France
      • 9.4.4.1 France smart inhalers market, 2017 - 2030 (USD Million)
    • 9.4.5 Italy
      • 9.4.5.1 Italy Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.6 Spain
      • 9.4.6.1 Spain Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.7 Russia
      • 9.4.7.1 Russia smart inhalers market, 2017 - 2030 (USD Million)
  • 9.5 Asia Pacific
    • 9.5.1 Asia Pacific Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.2 Japan
      • 9.5.2.1 Japan Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.3 China
      • 9.5.3.1 China Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.4 India
      • 9.5.4.1 India Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.5 Australia
      • 9.5.5.1 Australia Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.6 South Korea
      • 9.5.6.1 South Korea Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.7 Singapore
      • 9.5.7.1 Singapore Smart inhalers market, 2017 - 2030 (USD Million)
  • 9.6 Latin America
    • 9.6.1 Latin America Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.2 Brazil
      • 9.6.2.1 Brazil Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.3 Mexico
      • 9.6.3.1 Mexico Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.4 Argentina
      • 9.6.4.1 Argentina Smart Inhalers market, 2017 - 2030 (USD Million)
  • 9.7 Middle East and Africa (MEA)
    • 9.7.1 MEA Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.7.2 South Africa
      • 9.7.2.1 South Africa Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.7.3 Saudi Arbia
      • 9.7.3.1 Saudi Arbia smart inhalers market, 2017 - 2030 (USD Million)
    • 9.7.4 UAE
      • 9.7.4.1 UAE smart inhalers market, 2017 - 2030 (USD Million)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2 Company Profiles
    • 10.2.1 H&T PRESSPART MANUFACTURING LTD.
      • 10.2.1.1 Company overview
      • 10.2.1.2 Financial performance
      • 10.2.1.3 Product benchmarking
      • 10.2.1.4 Strategic initiatives
    • 10.2.2 PERSONAL AIR QUALITY SYSTEMS PRIVATE LIMITED
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial performance
      • 10.2.2.3 Product benchmarking
      • 10.2.2.4 Strategic initiatives
    • 10.2.3 COHERO HEALTH INC.
      • 10.2.3.1 Company overview
      • 10.2.3.2 Financial performance
      • 10.2.3.3 Product benchmarking
      • 10.2.3.4 Strategic initiatives
    • 10.2.4 COGNITA LABS
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial performance
      • 10.2.2.3 Product benchmarking
      • 10.2.2.4 Strategic initiatives
    • 10.2.4 ADHERIUM LIMITED
      • 10.2.4.1 Company overview
      • 10.2.4.2 Financial performance
      • 10.2.4.3 Product benchmarking
      • 10.2.4.4 Strategic initiatives
    • 10.2.5 AMIKO DIGITAL HEALTH LIMITED
      • 10.2.5.1 Company overview
      • 10.2.5.2 Financial performance
      • 10.2.5.3 Product benchmarking
      • 10.2.5.4 Strategic initiatives
    • 10.2.6 TEVA PHARMACEUTICALS INDUSTRIES LTD.
      • 10.2.6.1 Company overview
      • 10.2.6.2 Financial performance
      • 10.2.6.3 Product benchmarking
      • 10.2.6.4 Strategic initiatives
    • 10.2.7 PROPELLER HEALTH
      • 10.2.7.1 Company overview
      • 10.2.7.2 Financial performance
      • 10.2.7.3 Product benchmarking
      • 10.2.7.4 Strategic initiatives
    • 10.2.8 NOVARTIS AG
      • 10.2.8.1 Company overview
      • 10.2.8.2 Financial performance
      • 10.2.8.3 Product benchmarking
      • 10.2.8.4 Strategic initiatives
    • 10.2.9 PNEUMA RESPIRATORY, INC.
      • 10.2.9.1 Company overview
      • 10.2.9.2 Financial performance
      • 10.2.9.3 Product benchmarking
      • 10.2.9.4 Strategic initiatives
    • 10.2.10 3M HEALTH CARE LIMITED
      • 10.2.10.1 Company overview
      • 10.2.10.2 Financial performance
      • 10.2.10.3 Product benchmarking
      • 10.2.10.4 Strategic initiatives
    • 10.2.11 FINDAIR SP. Z O.O.
      • 10.2.11.1 Company overview
      • 10.2.11.2 Financial performance
      • 10.2.11.3 Product benchmarking
      • 10.2.11.4 Strategic initiatives
    • 10.2.12 AIREHEALTH, INC.
      • 10.2.12.1 Company overview
      • 10.2.12.2 Financial performance
      • 10.2.12.3 Product benchmarking
      • 10.2.12.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 North America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 3 North America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 4 North America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 5 North America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 6 North America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 9 U.S. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 10 U.S. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 11 Canada smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 13 Canada smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 14 Canada smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 15 Europe smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 16 Europe smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 17 Europe smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 18 Europe smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 19 Europe smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 20 U.K. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 21 U.K. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 22 U.K. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 23 U.K. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 24 Germany smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 25 Germany smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 26 Germany smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 27 Germany smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 28 France smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 29 France smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 30 France smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 31 France smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 32 Italy smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 33 Italy Smart Inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 34 Italy smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 35 Italy smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 36 Spain smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 37 Spain smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 38 Spain smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 39 Spain smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 40 Russia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 41Russia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 42 Russia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 43 Russia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 44 Asia Pacific smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 45 Asia Pacific smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 46 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 47 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 48 Asia Pacific smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 49 Japan smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 50 Japan smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 51 Japan smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 52 Japan smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 53 China smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 54 China smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 55 China smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 56 China smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 57 India smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 58 India smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 59 India smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 60 India smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 61 Australia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 Australia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 Australia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 Australia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)'
  • Table 61 South Korea smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 South Korea smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 South Korea smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 61 Singapore smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 Singapore smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 Singapore smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 Singapore smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 65 Latin America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 66 Latin America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 67 Latin America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 68 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 69 Latin America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 70 Brazil smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 71 Brazil smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 72 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 73 Brazil smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 74 Mexico smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 75 Mexico smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 76 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 77 Mexico smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 74 Argentina smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 75 Argentina smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 76 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 77 Argentina smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 78 MEA smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 71 MEA smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 72 MEA smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 73 MEA smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 74 MEA smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 South Africa smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 South Africa smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 South Africa smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 Saudi Arabia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 UAE smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 UAE smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 UAE smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 UAE smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Smart inhalers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Smart Inhalers market outlook, 2021 (USD Million)
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Smart inhalers type market share analysis, 2022 & 2030 (USD Million)
  • Fig. 15 Smart inhalers type market: Segment dashboard
  • Fig. 16 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)
  • Fig. 17 Dry powdered inhalers (DPIs) market, 2017 - 2030 (USD Million)
  • Fig. 18 Smart inhalers indication market share analysis, 2021 & 2030 (USD Million)
  • Fig. 19 Smart inhalers indication market: Segment dashboard
  • Fig. 20 Asthma market, 2017 - 2030 (USD Million)
  • Fig. 21 COPD market, 2017 - 2030 (USD Million)
  • Fig. 22 Others market, 2017 - 2030 (USD Million)
  • Fig. 23 Smart inhalers distribution channel market share analysis, 2021 & 2030 (USD Million)
  • Fig. 24 Smart inhalers distribution channel market: Segment dashboard
  • Fig. 25 Hospital pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 26 Retail pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 27 Online pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 28 Smart inhalers end-use market share analysis, 2021 & 2030 (USD Million)
  • Fig. 29 Smart inhalers end-use market: Segment dashboard
  • Fig. 30 Hospitals market segmentation market, 2017 - 2030 (USD Million)
  • Fig. 31 Homecare settings market segmentation market, 2017 - 2030 (USD Million)
  • Fig. 32 Smart inhalers regional market share analysis, 2021 & 2030 (USD Million)
  • Fig. 33 Regional market place: Key takeaways
  • Fig. 34 North America smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 35 U.S. smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 36 Canada smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 37 Europe smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 38 U.K. smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 39 Germany smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 40 France smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 41 Italy smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 42 Spain smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 42 Russia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 43 Asia Pacific smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 44 Japan smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 45 China smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 India smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 Australia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 South Korea smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 Singapore smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 47 Latin America smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 48 Brazil smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 49 Mexico smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 49 Argentina smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 50 MEA smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 South Africa smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 UAE smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 52 Strategy framework